1999 perspective in drug industry: Drug revaluation and PMS

The new drug revaluation system implemented from 1995 seems to be substantially eased and converted to the PMS (Post marketing surveillance) after strengthening the revaluation and the monitoring of drug adverse reactions, the KFDA said.
The KFDA recognized that the drug revaluation system raised many problems including an exclusive marketing monopoly to the new drug and heavy personnel and ma...